MedPath

Treatment of bed sore with Platelet rich plasma in patients with spinal cord injury

Phase 1
Conditions
Health Condition 1: null- Spinal cord injured
Registration Number
CTRI/2021/09/036188
Lead Sponsor
Indian Council of Medical Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Participants with age more than 18 and less than 65 years.

2. Participants or close relative must be able to give voluntary written consent.

3. Participants with sacral PU with <3m duration.

4. Pressure ulcer of grade III & IV will be included in the study.

5. Participant who hospitalized for rehabilitation at ISIC will be included in the study.

Exclusion Criteria

1. Mental, psychiatric or cognitive disorder and /or pre-existing medical condition that might interfere with the outcomes.

2. Pressure sores associated with osteomyelitis, malignancy, leprosy and HIV (+ve)

3. Platelet dysfunction

4. Arterial origin of the cutaneous ulcers.

5. Active vasculitis,

6. Systemic lupus erythematosus, cryoglobulinemia,

7. Hematological abnormality or any coagulation abnormalities.

8. Current use of anticoagulants and/or treatment with immunosuppressant drugs;

9. Serum hemoglobin concentration <11 g/dL or hematocrit <34%;

10. Participant taking drug which might interfere with the study intervention like Anti- neoplastic drugs, steroids, antibiotics etc.

11. Drug or alcohol abuse..

12. Patient who smokes will be excluded from the study.

13. Diabetes (controlled/ Uncontrolled), uncontrolled hypertension, autoimmune disease, renal failure.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Size of pressure ulcer (percentage of surface area healed).Timepoint: 5 week and 3 month
Secondary Outcome Measures
NameTimeMethod
Pressure Ulcers Scale for Healing (PUSH) <br/ ><br>Depth of pressure ulcers <br/ ><br>Quality of Life using SF 36 <br/ ><br>4. Participant impression of change using visual analogue scale (VAS) <br/ ><br>5. Clinician impression of change using VAS <br/ ><br>6. Participantsâ?? satisfaction using VAS <br/ ><br>7. Histo-pathological resultsTimepoint: 3 month from the day of randomization
© Copyright 2025. All Rights Reserved by MedPath